Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice
Memory impairments constitute a significant problem worldwide, and the COVID-19 pandemic dramatically increased the prevalence of cognitive deficits. Patients with cognitive deficits, specifically memory disturbances, have underlying comorbid conditions such as schizophrenia, anxiety, or depression....
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-03-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/16/3/399 |
| _version_ | 1797609544540487680 |
|---|---|
| author | Elżbieta Żmudzka Klaudia Lustyk Kinga Sałaciak Agata Siwek Jolanta Jaśkowska Marcin Kołaczkowski Jacek Sapa Karolina Pytka |
| author_facet | Elżbieta Żmudzka Klaudia Lustyk Kinga Sałaciak Agata Siwek Jolanta Jaśkowska Marcin Kołaczkowski Jacek Sapa Karolina Pytka |
| author_sort | Elżbieta Żmudzka |
| collection | DOAJ |
| description | Memory impairments constitute a significant problem worldwide, and the COVID-19 pandemic dramatically increased the prevalence of cognitive deficits. Patients with cognitive deficits, specifically memory disturbances, have underlying comorbid conditions such as schizophrenia, anxiety, or depression. Moreover, the available treatment options have unsatisfactory effectiveness. Therefore, there is a need to search for novel procognitive and anti-amnesic drugs with additional pharmacological activity. One of the important therapeutic targets involved in the modulation of learning and memory processes are serotonin receptors, including 5-HT<sub>1A</sub>, 5-HT<sub>6</sub>, and 5-HT<sub>7</sub>, which also play a role in the pathophysiology of depression. Therefore, this study aimed to assess the anti-amnesic and antidepressant-like potential of JJGW08, a novel arylpiperazine alkyl derivative of salicylamide with strong antagonistic properties at 5-HT<sub>1A</sub> and D<sub>2</sub> receptors and weak at 5-HT<sub>2A</sub> and 5-HT<sub>7</sub> receptors in rodents. First, we investigated the compound’s affinity for 5-HT<sub>6</sub> receptors using the radioligand assays. Next, we assessed the influence of the compound on long-term emotional and recognition memory. Further, we evaluated whether the compound could protect against MK-801-induced cognitive impairments. Finally, we determined the potential antidepressant-like activity of the tested compound. We found that JJGW08 possessed no affinity for 5-HT<sub>6</sub> receptors. Furthermore, JJGW08 protected mice against MK-801-induced recognition and emotional memory deficits but showed no antidepressant-like effects in rodents. Therefore, our preliminary study may suggest that blocking serotonin receptors, especially 5-HT<sub>1A</sub> and 5-HT<sub>7</sub>, might be beneficial in treating cognitive impairments, but it requires further investigation. |
| first_indexed | 2024-03-11T06:02:55Z |
| format | Article |
| id | doaj.art-14281d0bf07a4c3fa2b1e60717b985a3 |
| institution | Directory Open Access Journal |
| issn | 1424-8247 |
| language | English |
| last_indexed | 2024-03-11T06:02:55Z |
| publishDate | 2023-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceuticals |
| spelling | doaj.art-14281d0bf07a4c3fa2b1e60717b985a32023-11-17T13:12:16ZengMDPI AGPharmaceuticals1424-82472023-03-0116339910.3390/ph16030399Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in MiceElżbieta Żmudzka0Klaudia Lustyk1Kinga Sałaciak2Agata Siwek3Jolanta Jaśkowska4Marcin Kołaczkowski5Jacek Sapa6Karolina Pytka7Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, PolandDepartment of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, PolandDepartment of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, PolandDepartment of Pharmacobiology, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, PolandDepartment of Organic Chemistry and Technology, Faculty of Chemical and Engineering and Technology, Cracow University of Technology, 31-155 Krakow, PolandDepartment of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, PolandDepartment of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, PolandDepartment of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, PolandMemory impairments constitute a significant problem worldwide, and the COVID-19 pandemic dramatically increased the prevalence of cognitive deficits. Patients with cognitive deficits, specifically memory disturbances, have underlying comorbid conditions such as schizophrenia, anxiety, or depression. Moreover, the available treatment options have unsatisfactory effectiveness. Therefore, there is a need to search for novel procognitive and anti-amnesic drugs with additional pharmacological activity. One of the important therapeutic targets involved in the modulation of learning and memory processes are serotonin receptors, including 5-HT<sub>1A</sub>, 5-HT<sub>6</sub>, and 5-HT<sub>7</sub>, which also play a role in the pathophysiology of depression. Therefore, this study aimed to assess the anti-amnesic and antidepressant-like potential of JJGW08, a novel arylpiperazine alkyl derivative of salicylamide with strong antagonistic properties at 5-HT<sub>1A</sub> and D<sub>2</sub> receptors and weak at 5-HT<sub>2A</sub> and 5-HT<sub>7</sub> receptors in rodents. First, we investigated the compound’s affinity for 5-HT<sub>6</sub> receptors using the radioligand assays. Next, we assessed the influence of the compound on long-term emotional and recognition memory. Further, we evaluated whether the compound could protect against MK-801-induced cognitive impairments. Finally, we determined the potential antidepressant-like activity of the tested compound. We found that JJGW08 possessed no affinity for 5-HT<sub>6</sub> receptors. Furthermore, JJGW08 protected mice against MK-801-induced recognition and emotional memory deficits but showed no antidepressant-like effects in rodents. Therefore, our preliminary study may suggest that blocking serotonin receptors, especially 5-HT<sub>1A</sub> and 5-HT<sub>7</sub>, might be beneficial in treating cognitive impairments, but it requires further investigation.https://www.mdpi.com/1424-8247/16/3/399anti-amnesic effectlong-term memorycognitionantidepressant-like activityserotonin receptors |
| spellingShingle | Elżbieta Żmudzka Klaudia Lustyk Kinga Sałaciak Agata Siwek Jolanta Jaśkowska Marcin Kołaczkowski Jacek Sapa Karolina Pytka Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice Pharmaceuticals anti-amnesic effect long-term memory cognition antidepressant-like activity serotonin receptors |
| title | Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice |
| title_full | Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice |
| title_fullStr | Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice |
| title_full_unstemmed | Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice |
| title_short | Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice |
| title_sort | potential anti amnesic activity of a novel multimodal derivative of salicylamide jjgw08 in mice |
| topic | anti-amnesic effect long-term memory cognition antidepressant-like activity serotonin receptors |
| url | https://www.mdpi.com/1424-8247/16/3/399 |
| work_keys_str_mv | AT elzbietazmudzka potentialantiamnesicactivityofanovelmultimodalderivativeofsalicylamidejjgw08inmice AT klaudialustyk potentialantiamnesicactivityofanovelmultimodalderivativeofsalicylamidejjgw08inmice AT kingasałaciak potentialantiamnesicactivityofanovelmultimodalderivativeofsalicylamidejjgw08inmice AT agatasiwek potentialantiamnesicactivityofanovelmultimodalderivativeofsalicylamidejjgw08inmice AT jolantajaskowska potentialantiamnesicactivityofanovelmultimodalderivativeofsalicylamidejjgw08inmice AT marcinkołaczkowski potentialantiamnesicactivityofanovelmultimodalderivativeofsalicylamidejjgw08inmice AT jaceksapa potentialantiamnesicactivityofanovelmultimodalderivativeofsalicylamidejjgw08inmice AT karolinapytka potentialantiamnesicactivityofanovelmultimodalderivativeofsalicylamidejjgw08inmice |